Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Identifieur interne : 001761 ( Main/Corpus ); précédent : 001760; suivant : 001762Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Auteurs : Amin Gasmi ; Sadaf Noor ; Torsak Tippairote ; Maryam Dadar ; Alain Menzel ; Geir Bj RklundSource :
- Clinical immunology (Orlando, Fla.) [ 1521-7035 ] ; 2020.
English descriptors
- KwdEn :
- Age Factors (MeSH), Antiviral Agents (therapeutic use), Betacoronavirus (drug effects), Betacoronavirus (genetics), Betacoronavirus (pathogenicity), Communicable Disease Control (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (metabolism), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Diet (methods), Female (MeSH), Gastrointestinal Microbiome (immunology), Humans (MeSH), Hygiene (education), Immunization, Passive (methods), Life Style (MeSH), Male (MeSH), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (metabolism), Pneumonia, Viral (prevention & control), Pneumonia, Viral (therapy), Precision Medicine (methods), Risk Management (methods), Severity of Illness Index (MeSH), Sex Factors (MeSH), Smoking (physiopathology).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- drug effects : Betacoronavirus.
- education : Hygiene.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- genetics : Betacoronavirus.
- immunology : Gastrointestinal Microbiome.
- metabolism : Coronavirus Infections, Pneumonia, Viral.
- methods : Diet, Immunization, Passive, Precision Medicine, Risk Management.
- pathogenicity : Betacoronavirus.
- physiopathology : Smoking.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Age Factors, Communicable Disease Control, Female, Humans, Life Style, Male, Severity of Illness Index, Sex Factors.
Abstract
It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.
DOI: 10.1016/j.clim.2020.108409
PubMed: 32276137
PubMed Central: PMC7139252
Links to Exploration step
pubmed:32276137Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.</title><author><name sortKey="Gasmi, Amin" sort="Gasmi, Amin" uniqKey="Gasmi A" first="Amin" last="Gasmi">Amin Gasmi</name><affiliation><nlm:affiliation>Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Noor, Sadaf" sort="Noor, Sadaf" uniqKey="Noor S" first="Sadaf" last="Noor">Sadaf Noor</name><affiliation><nlm:affiliation>Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.</nlm:affiliation></affiliation></author><author><name sortKey="Tippairote, Torsak" sort="Tippairote, Torsak" uniqKey="Tippairote T" first="Torsak" last="Tippairote">Torsak Tippairote</name><affiliation><nlm:affiliation>Nutritional and Environmental Medicine Department, BBH Hospital, Bangkok, Thailand; Faculty of Medicine, Ramathibodi Hospital and Institute of Nutrition, Mahidol University, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Dadar, Maryam" sort="Dadar, Maryam" uniqKey="Dadar M" first="Maryam" last="Dadar">Maryam Dadar</name><affiliation><nlm:affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Menzel, Alain" sort="Menzel, Alain" uniqKey="Menzel A" first="Alain" last="Menzel">Alain Menzel</name><affiliation><nlm:affiliation>Laboratoires Réunis, Junglinster, Luxembourg.</nlm:affiliation></affiliation></author><author><name sortKey="Bj Rklund, Geir" sort="Bj Rklund, Geir" uniqKey="Bj Rklund G" first="Geir" last="Bj Rklund">Geir Bj Rklund</name><affiliation><nlm:affiliation>Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway. Electronic address: bjorklund@conem.org.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32276137</idno><idno type="pmid">32276137</idno><idno type="doi">10.1016/j.clim.2020.108409</idno><idno type="pmc">PMC7139252</idno><idno type="wicri:Area/Main/Corpus">001761</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001761</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.</title><author><name sortKey="Gasmi, Amin" sort="Gasmi, Amin" uniqKey="Gasmi A" first="Amin" last="Gasmi">Amin Gasmi</name><affiliation><nlm:affiliation>Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Noor, Sadaf" sort="Noor, Sadaf" uniqKey="Noor S" first="Sadaf" last="Noor">Sadaf Noor</name><affiliation><nlm:affiliation>Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.</nlm:affiliation></affiliation></author><author><name sortKey="Tippairote, Torsak" sort="Tippairote, Torsak" uniqKey="Tippairote T" first="Torsak" last="Tippairote">Torsak Tippairote</name><affiliation><nlm:affiliation>Nutritional and Environmental Medicine Department, BBH Hospital, Bangkok, Thailand; Faculty of Medicine, Ramathibodi Hospital and Institute of Nutrition, Mahidol University, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Dadar, Maryam" sort="Dadar, Maryam" uniqKey="Dadar M" first="Maryam" last="Dadar">Maryam Dadar</name><affiliation><nlm:affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Menzel, Alain" sort="Menzel, Alain" uniqKey="Menzel A" first="Alain" last="Menzel">Alain Menzel</name><affiliation><nlm:affiliation>Laboratoires Réunis, Junglinster, Luxembourg.</nlm:affiliation></affiliation></author><author><name sortKey="Bj Rklund, Geir" sort="Bj Rklund, Geir" uniqKey="Bj Rklund G" first="Geir" last="Bj Rklund">Geir Bj Rklund</name><affiliation><nlm:affiliation>Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway. Electronic address: bjorklund@conem.org.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Clinical immunology (Orlando, Fla.)</title><idno type="eISSN">1521-7035</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors (MeSH)</term><term>Antiviral Agents (therapeutic use)</term><term>Betacoronavirus (drug effects)</term><term>Betacoronavirus (genetics)</term><term>Betacoronavirus (pathogenicity)</term><term>Communicable Disease Control (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (metabolism)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Diet (methods)</term><term>Female (MeSH)</term><term>Gastrointestinal Microbiome (immunology)</term><term>Humans (MeSH)</term><term>Hygiene (education)</term><term>Immunization, Passive (methods)</term><term>Life Style (MeSH)</term><term>Male (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (metabolism)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (therapy)</term><term>Precision Medicine (methods)</term><term>Risk Management (methods)</term><term>Severity of Illness Index (MeSH)</term><term>Sex Factors (MeSH)</term><term>Smoking (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="education" xml:lang="en"><term>Hygiene</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Gastrointestinal Microbiome</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Diet</term><term>Immunization, Passive</term><term>Precision Medicine</term><term>Risk Management</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Smoking</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Factors</term><term>Communicable Disease Control</term><term>Female</term><term>Humans</term><term>Life Style</term><term>Male</term><term>Severity of Illness Index</term><term>Sex Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32276137</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-7035</ISSN><JournalIssue CitedMedium="Internet"><Volume>215</Volume><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>Clinical immunology (Orlando, Fla.)</Title><ISOAbbreviation>Clin. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.</ArticleTitle><Pagination><MedlinePgn>108409</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1521-6616(20)30225-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2020.108409</ELocationID><Abstract><AbstractText>It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gasmi</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noor</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tippairote</LastName><ForeName>Torsak</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nutritional and Environmental Medicine Department, BBH Hospital, Bangkok, Thailand; Faculty of Medicine, Ramathibodi Hospital and Institute of Nutrition, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadar</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menzel</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoires Réunis, Junglinster, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjørklund</LastName><ForeName>Geir</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway. Electronic address: bjorklund@conem.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Immunol</MedlineTA><NlmUniqueID>100883537</NlmUniqueID><ISSNLinking>1521-6616</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000705128">COVID-19 serotherapy</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin Immunol. 2020 Jul;216:108465</RefSource><PMID Version="1">32417594</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006920" MajorTopicYN="N">Hygiene</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012308" MajorTopicYN="N">Risk Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antiviral medication</Keyword><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Diet</Keyword><Keyword MajorTopicYN="Y">Herbs</Keyword><Keyword MajorTopicYN="Y">Lifestyle</Keyword><Keyword MajorTopicYN="Y">Nutrition</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-II</Keyword><Keyword MajorTopicYN="Y">Smoking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32276137</ArticleId><ArticleId IdType="pii">S1521-6616(20)30225-4</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2020.108409</ArticleId><ArticleId IdType="pmc">PMC7139252</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001761 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001761 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32276137
|texte= Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32276137" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |